McKenna's Pharmacology for Nursing, 2e

977

Index

Cardiovascular system, 642–654 anaemias, drugs used to treat. See Anaemias, drugs used to treat antiarrhythmic agents. See Antiarrhythmic agents blood coagulation, drugs affecting. See Coagulation, drugs affecting blood pressure, drugs affecting. See Blood pressure, drugs affecting cardiotonic agents. See Cardiotonic agents circulation, 649–653 electrocardiography, 646–648 arrhythmias, 647–648 lipid-lowering agents. See Lipid- lowering agents parasympathetic blockade, effects, 505 structure and function of the heart, 643–646 Carmustine, 195, 196 Carvedilol, 470, 472, 676 Cascara, 919 Caspofungin, 152, 154–155 Castor oil, 918 Catecholamines, 575 Cathartic dependence, 916, 919 Catnip leaves, 963 Cat’s claw, 963 Cayenne pepper, 963 CCR5 coreceptor antagonist, 126, 136, 141 Cefaclor, 90, 100, 101, 102

exocytosis, 72, 76 homeostasis, 76 osmosis, 72, 77 passive transport, 76–77 receptor sites, 74 Cellular defences, 230–231 basophils, 230 eosinophils, 230 lymphoid tissues, 231 monocytes/macrophages, 228, 230–231 neutrophils, 230 Central and peripheral nervous system, drugs acting on anaesthetic agents. See Anaesthetic agents antidepressant agents. See Antidepressant agents antiparkinsonism agents. See Antiparkinsonism agents antiseizure agents. See Antiseizure agents anxiolytic and hypnotic agents. See Anxiolytic and hypnotic agents muscle relaxants. See Muscle relaxants nerves and the nervous system. See Nerves and the nervous system neuromuscular junction blocking agents. See Neuromuscular junction blocking agents opioids See Opioids, opioid antagonists and antimigraine agents parasympathetic blockade, effects, 505 psychotherapeutic agents. See Psychotherapeutic agents Central nervous system, 297–300 brain anatomy, 298–299 functions, 299–300 parasympathetic blockade, effects, 505 spinal cord anatomy, 299 stimulants, 347–349 adverse effects, 348 care considerations, 348–349 contraindications and cautions, 348 drug–drug interactions, 348 pharmacokinetics, 348 therapeutic actions and indications, 348 Centre for Adverse Reaction and Monitoring (CARM), 65 Cephalexin, 100, 101 Cephalosporins, 90, 99–103 adverse effects, 101–102 calculations, 101 care considerations, 102–103 contraindications and cautions, 101 drug–drug interactions, 102 pharmacokinetics, 101 therapeutic actions and indications, 101

Cetuximab, 266 Chagas disease, 163, 172 Chamomile, 963

Chaste tree, 613, 963 Chelating agents, 784 Chemical name, 2, 5, 7 Chemical stimulant laxatives, 916, 918–919, 920 adverse effects, 918–919 contraindications and cautions, 918 drug–drug interactions, 919 pharmacokinetics, 918 therapeutic actions and indications, 918 Chemoreceptor trigger zone (CTZ), 199–200, 399 Chemotaxis, 228, 231–232 Chemotherapeutic agents, 15, 16, 73 anthelmintic agents. See Anthelmintic agents antibiotics. See Antibiotics antifungal agents. See Antifungal agents anti-infective agents. See Anti-infective agents antineoplastic agents. See Antineoplastic agents antiprotozoal agents. See Antiprotozoal agents antiviral agents. See Antiviral agents cell physiology. See Cell physiology Cheyne–Stokes respiration, 864, 868 Chicken soup, 963 Chicory, 963 Children adrenergic agonists, 456 anthelmintic agents, 183 antianginal agents, 717 antiarrhythmic agents, 701 antibiotics, 93 anticholinergic agents, 502 antidepressant agents, 318 antiemetic agents, 931 antifungal agents, 151 anti-infective agents, 82 anti-inflammatory agents, 241 antimigraine agents, 410 antineoplastic agents, 194 antiparkinsonism agents, 375 antiprotozoal agents, 164 antiseizure agents, 354 antiviral agents, 128 anxiolytic and hypnotic agents, 304 blood pressure, drugs affecting, 666 cardiotonic agents, 686 cholinergic agonists, 489 coagulation, drugs affecting, 752 corticosteroids, 540 cough and cold products, 854 adrenergic blocking agents, 471 anaemias, drugs used to treat, 779

Cefalotin, 100, 101 Cefepime, 100, 101 Cefotaxime, 100, 101 Cefoxitin, 100, 101 Ceftaroline, 100, 101 Ceftazidime, 100, 101 Ceftriaxone, 100, 101 Cefuroxime, 100, 101 Celecoxib, 195, 247, 248 Celery, 471, 582, 963 Cells, 73–75 cellular actions, sites, 92

channels, 74 cycle, 72, 78

G0 phase, 78 G1 phase, 78 G2 phase, 78 M phase, 78 S phase, 78 cytoplasm, 72, 75 endoplasmic reticulum, 72, 75 identifying markers, 74 kill theory, 193 lipoproteins, 72, 73–74 lysosomes, 72, 75

membrane, 72, 73–74 mitochondria, 72, 75 nucleus, 72, 73 physiology, 72–79 interference with, 83 properties, 75–77 active transport, 77 diffusion, 72, 76–77 endocytosis, 72, 75–76

Cephazolin, 100, 101 Cerebellum, 385, 386

Cerebral palsy, 393–394 Certolizumab, 264, 266 Cervical cancer vaccine, 281 Cestodes, 179, 180, 181 Cetirizine, 853, 854 Cetrorelix, 523, 524, 617, 618

digoxin toxicity, 688 diuretic agents, 806 drug administration, 49

dosage calculations, 57–58, 306 female reproductive system, drugs affecting, 608